Chronic treatment with Mirabegron improves cardiovascular reactivity in spontaneously hypertensive rats with metabolic syndrome
ConclusionThe main results showed protective cardiovascular effects of mirabegron, making ß3-adrenergic receptor activation a promising option to consider during metabolic syndrome.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Diets | Eating Disorders & Weight Management | Heart | Metabolic Syndrome | Nutrition | Obesity | Overactive Bladder | Overactive Bladder Syndrome | Perfusion | Study